创伤性脑损伤合并失血性休克患者的结局:PROPPR试验二次分析
该研究为PROPPR试验的事后分析,纳入670例患者。创伤性脑损伤定义为头部简明损伤定级评分大于2,失血性休克定义为基础剩余≤-4和/或休克指数≥0.9。主要结局为30天死亡率。创伤性脑损伤合并失血性休克组未调整死亡率为51.6%,创伤性脑损伤组为50%,失血性休克组为17.5%,两者均无组为7.7%。调整后,创伤性脑损伤组和创伤性脑损伤合并失血性休克组的死亡比值比分别为8.2(95%CI 3.4-19.5)和10.6(95%CI 4.8-23.2)。创伤性脑损伤合并失血性休克组乳酸中位数6.3(IQR 4.7-9.2)高于创伤性脑损伤组的3.3(IQR 2.3-4)。
要点
- 创伤性脑损伤合并失血性休克患者30天未调整死亡率为51.6%,创伤性脑损伤组为50%,失血性休克组为17.5%,两者均无组为7.7%。
- 调整已知混杂因素后,创伤性脑损伤合并失血性休克组死亡比值比为10.6(95%CI 4.8-23.2),创伤性脑损伤组为8.2(95%CI 3.4-19.5)。
- 创伤性脑损伤合并失血性休克组乳酸中位数6.3(IQR 4.7-9.2),高于创伤性脑损伤组的3.3(IQR 2.3-4)。
- 创伤性脑损伤合并失血性休克组活化凝血酶原时间更高、血小板计数更低,提示复苏前凝血功能障碍更重。
- 创伤性脑损伤或创伤性脑损伤合并失血性休克组呼吸并发症比值比显著高于两者均无组,无呼吸机日、无ICU日和无住院日更少。
适用人群与场景
- PROPPR试验纳入的670例严重创伤患者,该分析为事后分析。
- 创伤性脑损伤定义为头部简明损伤定级评分大于2。
- 失血性休克定义为基础剩余≤-4和/或休克指数≥0.9。
诊断标准与关键阈值
- 创伤性脑损伤:头部简明损伤定级评分大于2。
- 失血性休克:基础剩余≤-4和/或休克指数≥0.9。
研究设计与关键结果
- 研究类型:PROPPR试验事后分析,纳入670例患者。
- 主要结局30天未调整死亡率:创伤性脑损伤合并失血性休克组51.6%,创伤性脑损伤组50%,失血性休克组17.5%,两者均无组7.7%。
- 调整后死亡比值比:创伤性脑损伤组8.2(95%CI 3.4-19.5),创伤性脑损伤合并失血性休克组10.6(95%CI 4.8-23.2)。
- 创伤性脑损伤合并失血性休克组乳酸中位数6.3(IQR 4.7-9.2),创伤性脑损伤组3.3(IQR 2.3-4)。
- 创伤性脑损伤合并失血性休克组活化凝血酶原时间更高、血小板计数更低。
- 呼吸并发症:创伤性脑损伤合并失血性休克组或创伤性脑损伤组比值比显著高于两者均无组;无呼吸机日、无ICU日和无住院日更少。
证据类型、等级与局限
- 证据类型:PROPPR试验的事后分析,预后研究,证据等级II级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于创伤性脑损伤合并失血性休克患者,急诊与ICU团队应意识到其复苏前凝血功能障碍更重、死亡率更高,作者认为这可能有助于优先安排紧急处理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Often the clinician is faced with a diagnostic and therapeutic dilemma in patients with concomitant traumatic brain injury (TBI) and hemorrhagic shock (HS), as rapid deterioration from either can be fatal. Knowledge about outcomes after concomitant TBI and HS may help prioritize the emergent management of these patients. We hypothesized that patients with concomitant TBI and HS (TBI + HS) had worse outcomes and required more intensive care compared with patients with only one of these injuries.
METHODS: This is a post hoc analysis of the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial. TBI was defined by a head Abbreviated Injury Scale score greater than 2. HS was defined as a base excess of -4 or less and/or shock index of 0.9 or greater. The primary outcome for this analysis was mortality at 30 days. Logistic regression, using generalized estimating equations, was used to model categorical outcomes.
RESULTS: Six hundred seventy patients were included. Patients with TBI + HS had significantly higher lactate (median, 6.3; interquartile range, 4.7-9.2) compared with the TBI group (median, 3.3; interquartile range, 2.3-4). TBI + HS patients had higher activated prothrombin times and lower platelet counts. Unadjusted mortality was higher in the TBI + HS (51.6%) and TBI (50%) groups compared with the HS (17.5%) and neither group (7.7%). Adjusted odds of death in the TBI and TBI + HS groups were 8.2 (95% confidence interval, 3.4-19.5) and 10.6 (95% confidence interval, 4.8-23.2) times higher, respectively. Ventilator, intensive care unit-free and hospital-free days were lower in the TBI and TBI + HS groups compared with the other groups. Patients with TBI + HS or TBI had significantly greater odds of developing a respiratory complication compared with the neither group.
CONCLUSION: The addition of TBI to HS is associated with worse coagulopathy before resuscitation and increased mortality. When controlling for multiple known confounders, the diagnosis of TBI alone or TBI+HS was associated with significantly greater odds of developing respiratory complications.
LEVEL OF EVIDENCE: Prognostic study, level II.
参考来源
- Galvagno SM, Fox EE, Appana SN, et al. Outcomes after concomitant traumatic brain injury and hemorrhagic shock: A secondary analysis from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios trial. J Trauma Acute Care Surg. 2017. PMID: 28930959. doi:10.1097/TA.0000000000001584
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。